Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28–MDM2–p53 complexes and by preventing the ubiquitination and degradation of p53

Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation

(2011) Zchong-Zcho Wu et al.   BIOCHEMICAL PHARMACOLOGY

Knockdown of NAPA using short-hairpin RNA sensitizes cancer cells to cisplatin: Implications to overcome chemoresistance

(2010) Zchong-Zcho Wu et al.   BIOCHEMICAL PHARMACOLOGY

Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells

(2010) Zchong-Zcho Wu et al.   BIOCHEMICAL PHARMACOLOGY

Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies

(2010) I Goldstein et al.   CANCER GENE THERAPY

Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis

(2010) Zchong-Zcho Wu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

p53 isoforms gain functions

(2010) V Olivares-Illana et al.   ONCOGENE

The relevance of protein-protein interactions for p53 function: the CPE contribution

(2010) M. R. Fernandez-Fernandez et al.   PROTEIN ENGINEERING DESIGN & SELECTION

Blinded by the Light: The Growing Complexity of p53

(2009) Karen H. Vousden et al.   CELL

The Isoforms of the p53 Protein

(2009) M. P. Khoury et al.   Cold Spring Harbor Perspectives in Biology

Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks

(2008) Anthony G. Uren et al.   CELL

Oscillations and bistability in the stochastic model of p53 regulation

(2008) Krzysztof Puszyński et al.   JOURNAL OF THEORETICAL BIOLOGY

The p53 family and programmed cell death

(2008) E C Pietsch et al.   ONCOGENE